CHEMOCENTRYX INC (CCXI)       51.99  +0.03 (+0.06%)

51.99  +0.03 (+0.06%)

US16383L1061 - Common Stock - After market: 51.99 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2019 2020 2021 2022 2023 2024 2025 2026
Revenue
36.13M
-15.74%		64.89M
79.60%		32.224M
-50.34%		73.845M
129.16%
EBITDA
-56.66M
-42.51%		-54.38M
4.02%		-126.78M
-133.14%		-130.458M
-2.90%
EBIT
-58.3M
-44.77%		-55.18M
5.35%		-129.919M
-135.45%		-122.735M
5.53%
Operating Margin
-161.36%-85.04%-403.17%-166.21%
EPS
-0.97
-27.63%		-0.84
13.40%		-1.89
-125.00%		-1.71
9.69%

All data in USD


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS-0.50
10.07%		-0.39
-20.59%
Revenue12.909M
612.00%		22.393M
26.21%
EBITDA-39.78M-39.78MN/AN/AN/AN/A
EBIT-35.653M
7.96%		-28.186M
-29.28%

All data in USD


EPS and Revenue Surprises


Recent Earnings VS Estimates (USD)
Period Reported Estimate Difference Surprise Q2 2022 -0.44 -0.50 0.0612.63% Q1 2022 -0.55 -0.32 -0.23-73.94% Q4 2021 -0.58 -0.60 0.022.59% Q3 2021 -0.32 -0.46 0.1429.70% Q2 2021 -0.56 -0.56 0.00-0.74% Q1 2021 -0.43 -0.41 -0.02-4.09% Q4 2020 -0.43 -0.34 -0.09-26.65% Q3 2020 -0.35 -0.32 -0.03-10.24%
Recent Revenue VS Estimates (USD)
Period Reported Estimate Difference Surprise Q2 2022 11.763M 12.909M -1.146M-8.87% Q1 2022 5.459M 21.797M -16.338M-74.96% Q4 2021 2.315M 4.307M -1.992M-46.25% Q3 2021 17.743M 13.746M 3.997M29.07% Q2 2021 1.813M 4.944M -3.131M-63.33% Q1 2021 10.35M 8.087M 2.263M27.98% Q4 2020 4.36M 8.154M -3.794M-46.53% Q3 2020 5.09M 10.915M -5.825M-53.37%

EPS and Revenue Revisions


Next Q (1 month)Next Q (3 month)Next Year (1 month)Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A